India
· Delayed Price · Currency is INR NSE:INDRAMEDCO Statistics
Total Valuation
NSE:INDRAMEDCO has a market cap or net worth of INR 36.50 billion. The enterprise value is 33.61 billion.
| Market Cap | 36.50B |
| Enterprise Value | 33.61B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Sep 13, 2024 |
Share Statistics
NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 91.67M |
| Shares Outstanding | 91.67M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 7.36% |
| Float | 40.99M |
Valuation Ratios
The trailing PE ratio is 22.67 and the forward PE ratio is 18.63.
| PE Ratio | 22.67 |
| Forward PE | 18.63 |
| PS Ratio | 2.69 |
| PB Ratio | 6.12 |
| P/TBV Ratio | 6.12 |
| P/FCF Ratio | 30.31 |
| P/OCF Ratio | 23.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.76, with an EV/FCF ratio of 27.91.
| EV / Earnings | 20.87 |
| EV / Sales | 2.48 |
| EV / EBITDA | 13.76 |
| EV / EBIT | 16.81 |
| EV / FCF | 27.91 |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.41 |
| Quick Ratio | 2.23 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.27 |
| Interest Coverage | 31.89 |
Financial Efficiency
Return on equity (ROE) is 29.97% and return on invested capital (ROIC) is 21.90%.
| Return on Equity (ROE) | 29.97% |
| Return on Assets (ROA) | 15.87% |
| Return on Invested Capital (ROIC) | 21.90% |
| Return on Capital Employed (ROCE) | 29.71% |
| Revenue Per Employee | 4.56M |
| Profits Per Employee | 540,779 |
| Employee Count | 2,977 |
| Asset Turnover | 1.72 |
| Inventory Turnover | 118.83 |
Taxes
In the past 12 months, NSE:INDRAMEDCO has paid 553.30 million in taxes.
| Income Tax | 553.30M |
| Effective Tax Rate | 25.58% |
Stock Price Statistics
The stock price has increased by +54.52% in the last 52 weeks. The beta is 0.59, so NSE:INDRAMEDCO's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +54.52% |
| 50-Day Moving Average | 414.62 |
| 200-Day Moving Average | 432.32 |
| Relative Strength Index (RSI) | 40.97 |
| Average Volume (20 Days) | 178,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:INDRAMEDCO had revenue of INR 13.56 billion and earned 1.61 billion in profits. Earnings per share was 17.56.
| Revenue | 13.56B |
| Gross Profit | 4.94B |
| Operating Income | 2.00B |
| Pretax Income | 2.16B |
| Net Income | 1.61B |
| EBITDA | 2.44B |
| EBIT | 2.00B |
| Earnings Per Share (EPS) | 17.56 |
Balance Sheet
The company has 3.22 billion in cash and 327.60 million in debt, giving a net cash position of 2.89 billion or 31.52 per share.
| Cash & Cash Equivalents | 3.22B |
| Total Debt | 327.60M |
| Net Cash | 2.89B |
| Net Cash Per Share | 31.52 |
| Equity (Book Value) | 5.97B |
| Book Value Per Share | 65.04 |
| Working Capital | 2.52B |
Cash Flow
In the last 12 months, operating cash flow was 1.57 billion and capital expenditures -363.30 million, giving a free cash flow of 1.20 billion.
| Operating Cash Flow | 1.57B |
| Capital Expenditures | -363.30M |
| Free Cash Flow | 1.20B |
| FCF Per Share | 13.14 |
Margins
Gross margin is 36.39%, with operating and profit margins of 14.74% and 11.87%.
| Gross Margin | 36.39% |
| Operating Margin | 14.74% |
| Pretax Margin | 15.95% |
| Profit Margin | 11.87% |
| EBITDA Margin | 18.01% |
| EBIT Margin | 14.74% |
| FCF Margin | 8.88% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 1.13%.
| Dividend Per Share | 4.50 |
| Dividend Yield | 1.13% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 25.30% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.12% |
| Earnings Yield | 4.41% |
| FCF Yield | 3.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |